Ascendiant Capital Maintains Buy on BioSig Technologies, Raises Price Target to $2.75

Benzinga12/05 17:43

BioSig Technologies Analyst Ratings

Benzinga12/05 17:40

バイオシグ・テクノロジーズ | 10-Q：Q3 2024 四半期報告書

SEC11/15 03:37

BioSig Regains Compliance With Nasdaq's Minimum Bid Price Requirement

GlobeNewswire11/14 04:14

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga10/29 04:30

BioSig Technologies' Common Stock To Resume Trading On The Nasdaq Exchange, Wednesday, October 23, 2024 After Its Appeal Was Granted An Extension Until March 7, 2025

Benzinga10/23 03:17